Biology Reference
In-Depth Information
4. Brines M et al (2000) Erythropoietin crosses
the blood-brain barrier to protect against
experimental brain injury. Proc Natl Acad Sci
U S A 97(19):10526-10531
5. Brines M, Cerami A (2005) Emerging biologi-
cal roles for erythropoietin in the nervous sys-
tem. Nat Rev Neurosci 6(6):484-494
6. Leist M et al (2004) Derivatives of erythropoi-
etin that are tissue protective but not erythro-
poietic. Science 305(5681):239-242
7. Brines M et al (2008) Nonerythropoietic, tis-
sue-protective peptides derived from the ter-
tiary structure of erythropoietin. Proc Natl
Acad Sci U S A 105:10925-10930
8. Duman RS, Heninger GR, Nestler EJ (1997)
A molecular and cellular theory of depression.
Arch Gen Psychiatry 54(7):597-606
9. Girgenti MJ et al (2009) Erythropoietin induc-
tion by electroconvulsive seizure, gene regula-
tion, and antidepressant-like behavioral effects.
Biol Psychiatry 66(3):267-274
10. Miskowiak K et al (2008) Erythropoietin
improves mood and modulates the cognitive
and neural processing of emotion 3 days post
administration.
18. Lucki I (1997) The forced swimming test as a
model for core and component behavioral
effects of antidepressant drugs. Behav
Pharmacol 8:523-532
19. Willner P (1990) Animal models of depres-
sion:
an
overview.
Pharmacol
Ther
45:425-455
20. Thiébot M-H, Martin P, Puech AJ (1992)
Animal behavioural studies in the evaluation of
antidepressant drugs. Br J Psychiatry
160:44-50
21. Bodnoff SR et al (1988) The effects of chronic
antidepressant treatment in an animal model
of anxiety. Psychopharmacology (Berl)
95(3):298-302
22. Bodnoff SR et al (1989) A comparison of the
effects of diazepam versus several typical and
atypical anti-depressant drugs in an animal
model of anxiety. Psychopharmacology (Berl)
97(2):277-279
23. Dulawa SC, Hen R (2005) Effects of chronic
fluoxetine in animal models of anxiety and
depression.
Neurosci
Biobehav
Rev
29(4-5):771-783
24. Kaufman J, Charney D (2000) Comorbidity of
mood and anxiety disorders. Depress Anxiety
12(Suppl 1):69-76
25. Ressler KJ, Nemeroff CB (2000) Role of sero-
tonergic and noradrenergic systems in the
pathophysiology of depression and anxiety dis-
orders. Depress Anxiety 12(Suppl 1):2-19
26. Serretti A et al (2009) Common genetic, clini-
cal, demographic and psychosocial predictors
of response to pharmacotherapy in mood and
anxiety disorders. Int Clin Psychopharmacol
24(1):1-18
27. Ennaceur A, Delacour J (1988) A new one-
trial test for neurobiological studies of memory
in rats. 1: Behavioral data. Behav Brain Res
31(1):47-59
28. Miskowiak K et al (2008) Differential effects
of erythropoietin on neural and cognitive
measures of executive function 3 and 7 days
post-administration.
Neuropsychopharmacology
33(3):611-618
11. Porsolt RD, Bertin A, Jalfre M (1977)
Behavioral despair in mice: a primary screening
test for antidepressants. Arch Int Pharmacodyn
Ther 229(2):327-336
12. Porsolt RD, Le Pichon M, Jalfre M (1977)
Depression: a new animal model sensitive to
antidepressant
treatments.
Nature
266(5604):730-732
13. Porsolt RD, Bertin A, Jalfre M (1978)
“Behavioural despair” in rats and mice: strain
differences and the effects of imipramine. Eur
J Pharmacol 51(3):291-294
14. Borsini F, Meli A (1988) Is the forced swim-
ming test a suitable model for revealing antide-
pressant activity? Psychopharmacology (Berl)
94:147-160
15. Shirayama Y et al (2002) Brain-derived neu-
rotrophic factor produces antidepressant
effects in behavioral models of depression.
J Neurosci 22(8):3251-3261
16. Duman CH et al (2009) Peripheral insulin-like
growth factor-I produces antidepressant-like
behavior and contributes to the effect of exer-
cise. Behav Brain Res 198(2):366-371
17. Detke MJ, Rickels M, Lucki I (1995) Active
behaviors in the rat forced swimming test dif-
ferentially produced by serotonergic and nora-
drenergic antidepressants. Psychopharmacology
(Berl) 121(1):66-72
Exp
Brain
Res
184(3):313-321
29. Ehrenreich H et al (2004) Erythropoietin: a
candidate compound for neuroprotection in
schizophrenia. Mol Psychiatry 9(1):42-54
30. Morgensen J et al (2008) Erythropoietin
improves spatial delayed alternation in a
T-maze in rats subjected to ablation of the pre-
frontal cortex. Brain Res Bull 77(1):1-7
31. Mun KC, Golper TA (2000) Impaired biologi-
cal activity of erythropoietin by cyanate car-
bamylation. Blood Purif 18:13-17
Search WWH ::
Custom Search